Expression of HERV-W env in human glioma cells results in a two- to fourfold increase in expression of brain-derived neurotrophic factor (BDNF), neurotrophic tyrosine kinase receptor type 2 (NTRK2), and dopamine receptor D3 (DRD3) (47). The gene discussed is BDNF; the disease is central nervous system cancer.